Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Novartis in the Pharma 50

Novartis

Rank: 5

2022 Rank: 5

Basel, Switzerland
www.novartis.com

2022 Revenues ($USD) : $50,545,000,000.00
2022 R&D spend : $9,996,000,000.00
2022 Number of Employees : 101,703
Fiscal Year End : 12/31/22
Leader : CEO Vas Narasimhan

Basel-based Novartis had a solid year in 2022, with Q4 sales increasing by 3% and full-year core operating income growth of 8%. Its Innovative Medicines division had a Q4 margin of 36.4% and a full-year margin of 36.9%. The company has been focusing on becoming a pure-play innovative medicines company, and with the planned spinoff of Sandoz, it aims to fully transition into this role, following similar recent moves by Pfizer, J&J and GSK. Novartis has guided to improved financials, with 4% sales growth and a core operating income margin goal of 40%. —BB
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE